Publications by authors named "Arlene Taylor"

Claim this Profile
A
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting in children: a randomised, double-blind, phase 3 trial.
Hyoung Jin Kang, Susan Loftus, Arlene Taylor, Cara DiCristina, Stuart Green

Lancet Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol--EASE.
Steven Grunberg, Daniel Chua, Anish Maru, José Dinis, Suzanne DeVandry, Arlene Taylor

J Clin Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Arnaldo L Colombo, Angela L Ngai, Michael Bourque, Susan K Bradshaw, Kim M Strohmaier, Arlene F Taylor

Antimicrob Agents Chemother· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia.
Johan A Maertens, Luis Madero, Anne F Reilly, Thomas Lehrnbecher, Andreas H Groll, Arlene F Taylor

Pediatr Infect Dis J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.
Bernardo L Rapoport, Karin Jordan, Judith A Boice, Arlene Taylor, Carole Brown

Support Care Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety experience with caspofungin in pediatric patients.
Theoklis Zaoutis, Thomas Lehrnbecher, Andreas H Groll, William J Steinbach, Hasan S Jafri, Arlene F Taylor

Pediatr Infect Dis J· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.
Robert F Betts, Marcio Nucci, Deepak Talwar, Marcelo Gareca, Flavio Queiroz-Telles, Arlene F Taylor

Clin Infect Dis· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
Theoklis E Zaoutis, Hasan S Jafri, Li-Min Huang, Franco Locatelli, Asher Barzilai, Arlene F Taylor

Pediatrics· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
Lia Gore, Sant Chawla, Antonio Petrilli, Molly Hemenway, Debra Schissel, Arlene Taylor

Pediatr Blood Cancer· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin for the treatment of less common forms of invasive candidiasis.
Oliver A Cornely, Martin Lasso, Robert Betts, Nickolay Klimko, Jose Vazquez, Arlene Taylor

J Antimicrob Chemother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Johan Maertens, Axel Glasmacher, Raoul Herbrecht, Anne Thiebaut, Catherine Cordonnier, Arlene Taylor

Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
Robert Betts, Axel Glasmacher, Johan Maertens, Georg Maschmeyer, Jose A Vazquez, Arlene Taylor

Cancer· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study.
Johan Maertens, Axel Glasmacher, Dominik Selleslag, Angela Ngai, Desmond Ryan, Arlene Taylor

Clin Infect Dis· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
David G Warr, Steven M Grunberg, Richard J Gralla, Paul J Hesketh, Fausto Roila, Arlene Taylor

Eur J Cancer· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
Nicholas A Kartsonis, Alfred J Saah, C Joy Lipka, Arlene F Taylor, Carole A Sable

J Infect· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
Johan Maertens, Issam Raad, George Petrikkos, Marc Boogaerts, Dominik Selleslag, Arlene Taylor

Clin Infect Dis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study.
Nicholas A Kartsonis, Alfred Saah, C Joy Lipka, Arlene Taylor, Carole A Sable

J Antimicrob Chemother· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Sant P Chawla, Steven M Grunberg, Richard J Gralla, Paul J Hesketh, Cindy Rittenberg, Arlene Taylor

Cancer· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis